Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia

February 17th 2022, 10:00pm

Article

A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.

FDA Halts Several Studies Examining Magrolimab-Onureg Combo Across Multiple Cancer Types Due to Serious Side Effects

January 28th 2022, 2:00pm

Article

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

Trial Underway for Potential First Treatment Option of Newly Diagnosed NPM1-Mutant AML

January 12th 2022, 2:30pm

Article

A phase 3 trial has begun to examine entospletinib, a selective inhibitor, as a treatment for patients with newly diagnosed NPM1-mutated acute myeloid leukemia.

mRNA COVID-19 Vaccination Sparks Strong Antibody Response in Patients With AML and MDS

December 13th 2021, 9:00pm

Article

Most patients with acute myeloid leukemia and myelodysplastic syndrome achieved strong antibody responses to COVID-19 vaccination, according to recent study results.

Kymriah May Be Safe and Effective in Children and Young Adults With Acute Lymphoblastic Leukemia Subtype

December 12th 2021, 5:11pm

Article

The immunotherapy Kymriah offered similar benefits in patients younger than and older than 18 years with relapsed/refractory B-cell acute lymphoblastic leukemia.

Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

December 12th 2021, 3:00pm

Article

Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

Phase 2 Trial Initiated for Second Line Treatment of AML and MDS

November 18th 2021, 12:00am

Article

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

New Drug Disappoints for Pancreatic Cancer and AML Treatment

October 29th 2021, 7:00pm

Article

Study results showed that CPI-613 did not improve survival in patients with metastatic adenocarcinoma of the pancreas.

‘Mommy Doesn’t Have Hair Right Now’: Receiving a Cancer Diagnosis as a Young Mother

October 28th 2021, 3:00pm

Podcast

On this episode of the “Cancer Horizons” podcast, CURE® contributor Amanda Ferraro describes what it was like to receive a cancer diagnosis at 28 years old with a 3-year-old child and discusses the importance of mental health for cancer survivors.

Better Days Ahead for Patients With AML

October 20th 2021, 9:00pm

Article

An abundance of clinical trials is giving patients with acute myeloid leukemia (AML) hope for a better future.